COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment

Encephalopathy is emerging as a recurrent complication of COVID-19 yet remains poorly characterized. We report the case of a middle-aged woman with COVID-19-related encephalopathy presenting as expressive aphasia and inattentiveness, subsequently progressing to agitation and marked confusion. Brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Muccioli, Lorenzo, Pensato, Umberto, Cani, Ilaria, Guerra, Luca, Provini, Federica, Bordin, Giorgio, Riccioli, Luca Albini, Lodi, Raffaele, Tinuper, Paolo, Bisulli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513756/
https://www.ncbi.nlm.nih.gov/pubmed/33032013
http://dx.doi.org/10.1016/j.jneuroim.2020.577400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513756/
https://www.ncbi.nlm.nih.gov/pubmed/33032013
http://dx.doi.org/10.1016/j.jneuroim.2020.577400

Ejemplares similares